Internal Medicine, Rheumatology · Vista, CA
NPI
1063594372
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2023 W Vista Way, Ste. J
Vista, CA, 92083
Phone (760) 724-6100
Groups this clinician bills Medicare through
Medicare paid, 2024
$66K
3,671 services
Medicare patients, 2024
153
Average age 75
Drug cost, 2024
$5.2M
3,810 prescriptions
Company payments, 2025
$2,244
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rashad Ansari was code J0897 (injection, denosumab, 1 mg), 1,127 times for 46 patients. In total Rashad Ansari billed 3,671 services in 18 codes, and Medicare paid $66K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-01-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,127 | 46 | $18.82 | $21K |
| 36415 Venipuncture Blood Collection | Office | 122 | 101 | $8.65 | $1,055 |
| 96372 Injection Administration | Office | 107 | 60 | $10.81 | $1,156 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 95 | 15 | $0.02 | $2.35 |
| 96413 Chemotherapy Administration | Office | 73 | 15 | $109.24 | $7,974 |
| 96365 Intravenous Infusion, Hydration | Office | 50 | 15 | $52.95 | $2,648 |
| 20610 Joint Injection | Office | 21 | 16 | $45.51 | $956 |
By year: 2022 $624K for 53,770 services; 2023 $595K for 42,229 services; 2024 $66K for 3,671 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 122 | 101 | $8.65 | $1,055 |
Medicare prescription drug claims, 2024
In 2024, the drug Rashad Ansari prescribed most often to Medicare patients was Prednisone, with 471 prescriptions and refills. In total Rashad Ansari wrote 3,810 Medicare prescriptions that cost $5.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 471 | 698 | 131 | $3,613 |
| Celecoxib Generic | 362 | 578 | 107 | $28K |
| Methotrexate Methotrexate Sodium | 225 | 461 | 50 | $5,510 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 168 | 168 | 37 | $3,413 |
| Humira Pen Adalimumab | 150 | 150 | 13 | $994K |
| Hydroxychloroquine Sulfate Generic | 140 | 307 | 31 | $6,652 |
| Meloxicam Generic | 136 | 242 | 46 | $459 |
| Xeljanz Xr Tofacitinib Citrate | 115 | 125 | 11 | $695K |
| Duloxetine Hcl Generic | 107 | 231 | 26 | $3,569 |
| Gabapentin Generic | 106 | 157 | 25 | $1,603 |
| Orencia Abatacept/Maltose | 106 | 106 | 11 | $457K |
| Prolia Denosumab | 105 | 630 | 69 | $171K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 102 | 102 | 16 | $3,208 |
| Pregabalin Generic | 85 | 128 | 18 | $3,133 |
| Allopurinol Generic | 78 | 186 | 18 | $1,336 |
Brand drugs: 978 claims; generic drugs: 2,832 claims; opioid claims: 418.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rashad Ansari $2,244 ($2,244 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $529.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 24 | $529 |
| Janssen Biotech, Inc. JNJ | 42 | $401 |
| UCB, Inc. UCB.BR | 9 | $290 |
| Amgen Inc. AMGN | 17 | $280 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $162 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $118 |
| Lilly USA, LLC LLY | 4 | $75.83 |
| Actelion Pharmaceuticals US, Inc. JNJ | 3 | $72.3 |
| Sandoz Inc. SDZ.SW | 3 | $62.07 |
| Pfizer Inc. PFE | 2 | $53.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.